Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Figgitt

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Drugs|March 15, 2002
Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystoniaDavid P Figgitt, Stuart Noble
Drugs & Aging|April 25, 2003
MemantineBlair Jarvis, David P Figgitt
Drugs|January 8, 2003
Combined two-dose hepatitis A and B vaccine (AmBirix)Blair Jarvis, David P Figgitt
CNS Drugs|March 3, 2005
Pregabalin: as adjunctive treatment of partial seizuresGreg Warner, David P Figgitt
Pharmacoeconomics|September 13, 2005
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infectionsGreg L Plosker, David P Figgitt
American Journal of Clinical Dermatology|March 12, 2003
Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratosesBlair Jarvis, David P Figgitt
Drugs|July 31, 2003
TipranavirGreg L Plosker, David P Figgitt
Drugs|April 3, 2004
Intravenous esomeprazoleGillian M Keating, David P Figgitt
Pharmacoeconomics|April 22, 2004
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitusGreg L Plosker, David P Figgitt
CNS Drugs|February 5, 2002
Spotlight on fluvoxamine in anxiety disorders in children and adolescentsSusan M Cheer, David P Figgitt
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Drugs|March 15, 2002
Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystoniaDavid P Figgitt, Stuart Noble
Drugs & Aging|April 25, 2003
MemantineBlair Jarvis, David P Figgitt
Drugs|January 8, 2003
Combined two-dose hepatitis A and B vaccine (AmBirix)Blair Jarvis, David P Figgitt
CNS Drugs|March 3, 2005
Pregabalin: as adjunctive treatment of partial seizuresGreg Warner, David P Figgitt
Pharmacoeconomics|September 13, 2005
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infectionsGreg L Plosker, David P Figgitt
American Journal of Clinical Dermatology|March 12, 2003
Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratosesBlair Jarvis, David P Figgitt
Drugs|July 31, 2003
TipranavirGreg L Plosker, David P Figgitt
Drugs|April 3, 2004
Intravenous esomeprazoleGillian M Keating, David P Figgitt
Pharmacoeconomics|April 22, 2004
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitusGreg L Plosker, David P Figgitt
CNS Drugs|February 5, 2002
Spotlight on fluvoxamine in anxiety disorders in children and adolescentsSusan M Cheer, David P Figgitt
Pageof 4